trenbolone mix sp laboratories

When applied to the skin betamethasone absorption can lead to systemic effects, especially when applied to extensive areas or inflamed skin under occlusive dressings. When topically  absorption of betamethasone through intact skin. Number vsosavshegosya Betamethasone is metabolised in the liver and excreted through the kidneys.
Systemic absorption of fusidic acid is negligible.

dermatitis, allergic drug reaction and eczema, infected by micro-organisms sensitive to fusidic acid.



  • Hypersensitivity to the drug.

Given the presence in the preparation trenbolone mix sp laboratories glucocorticosteroid drug is contraindicated in:


  • rosacea
  • perioral dermatitis
  • youth acne
  • Primary bacterial, viral and fungal skin diseases
  • Tuberculosis skin, syphilis (cutaneous manifestations)
  • Children aged up to one year

Pregnancy and lactation During pregnancy: Clinical data regarding the use of preperata Futsikort during pregnancy and lactation are not available. Experiments in animals have not shown teratogenic effects fusidic acid, but show such an effect in the application of glucocorticosteroids. The safety of using the outdoor corticosteroid therapy during pregnancy has not been established, given drugs group should be used only in the event that their application benefits outweigh any potential for mother the risks to the fetus. Pregnant women should not use this group of drugs in large doses or for a long time. When lactation: It is possible to use  during lactation. Women in the period of lactation should be trenbolone mix sp laboratories only on doctor’s advice. Corticosteroids are excreted in breast milk, but the probability of their impact on the breastfed baby is very small when topically to a limited area of the skin. If shown long-term treatment, or the use of high doses of the drug, should stop breastfeeding. During the period of lactation should not apply the cream on the breast.

Dosage and administration:
For external use only.
Adults and children: Apply a thin layer of the cream 2-3 times a day.
The course of treatment no more than 2 weeks.

Side effects
Side effects are classified according to frequency of occurrence:
the most common> 1/10
Frequent> 1/100 and <1/10
infrequent> 1/1000 and <1/100
Rare> 1/10000 and <1/1000
very rare < 1/10000 Violations of the immune system: frequency not known: allergic reactions part of the skin and skin appendages: Infrequent: rash, worsening of eczema, skin irritation, itching, burning sensation, or tingling of the skin. unknown frequency: skin atrophy, contact dermatitis, urticaria, erythema, skin dryness. Although these reactions were not observed in clinical studies trenbolone mix sp laboratories, external application glkzhokortiko steroids may lead to telangiectasia and striae, especially during prolonged use. As in the case of other glucocorticosteroids may develop folliculitis (steroid acne) , hypertrichosis, perioral dermatitis, depigmentation, hemorrhagic rash, rosacea, prickly heat, maceration of the skin and systemic effects of glucocorticoids.


Excessive prolonged trenbolone mix sp laboratories external treatment corticosteroids can suppress the function of the pituitary and adrenal glands, which can lead to secondary (usually reversible) adrenal insufficiency. In this case, symptomatic therapy may be indicated.